the pharmacokinetics of mitoxantrone , an anthraquinone antitumor agent , were cooperatively investigated at 5 institutions including 4 patients with breast cancer and 3 patients with malignant lymphoma .
C0026259
mitoxantrone
C0024299
malignant lymphoma